大行評級|摩根大通:中資汽車股依次偏好比亞迪、零跑、小鵬、理想及吉利
摩根大通報吿指,中資汽車股偏好依次為比亞迪、零跑汽車、小鵬汽車、理想汽車及吉利汽車。該行又指,乘聯會公佈上月批發略勝該行預期,受強勁新能源車增長及出口量推動。新能源車銷售強勁確認該行預期混能電動車及增程型電動車銷售跑贏電池電動車的主題,並預期中國汽車出口今年約650萬輛的,高於去年的590萬輛。該行指,美國汽車關税對中國汽車行業輕微,但警惕全球經濟增長放緩的潛在第二階段衝擊。與此同時,該行料全球車廠平均經營溢利受美國關税影響減少約三成,該行將觀察是否意味全球同業在國際市場應對中國車企上的財政彈性減低。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.